🚀 VC round data is live in beta, check it out!
FluoGuide Valuation Multiples
Discover revenue and EBITDA valuation multiples for FluoGuide and similar public comparables like Sensus Healthcare, Bioporto, Exagen, Aiforia and more.
FluoGuide Overview
About FluoGuide
FluoGuide AS is a clinical-stage biotechnology company focused on developing drugs that maximize surgical outcomes by making cancer fluorescent. Its technology includes uPAR, which is part of a proteolytic system, and FG001, a product injected into the patient's vein prior to surgery.
Founded
2018
HQ
Employees
8
Website
Financials (LTM)
EV
$66M
FluoGuide Financials
FluoGuide reported last 12-month revenue of — and negative EBITDA of ($7M).
In the same LTM period, FluoGuide generated — in gross profit, ($7M) in EBITDA losses, and had net loss of ($7M).
Revenue (LTM)
FluoGuide P&L
In the most recent fiscal year, FluoGuide reported revenue of — and EBITDA of ($6M).
FluoGuide expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA | ($7M) | XXX | ($6M) | XXX | XXX | XXX |
| Net Profit | ($7M) | XXX | ($6M) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
FluoGuide Stock Performance
FluoGuide has current market cap of $74M, and enterprise value of $66M.
Market Cap Evolution
FluoGuide's stock price is $4.52.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $66M | $74M | 0.3% | XXX | XXX | XXX | $-0.38 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialFluoGuide Valuation Multiples
FluoGuide trades at (9.8x) EV/EBITDA.
FluoGuide Financial Valuation Multiples
As of April 19, 2026, FluoGuide has market cap of $74M and EV of $66M.
Equity research analysts estimate FluoGuide's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
FluoGuide has a P/E ratio of (10.9x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $74M | XXX | $74M | XXX | XXX | XXX |
| EV (current) | $66M | XXX | $66M | XXX | XXX | XXX |
| EV/EBITDA | (9.8x) | XXX | (10.6x) | XXX | XXX | XXX |
| EV/EBIT | (9.6x) | XXX | (10.5x) | XXX | XXX | XXX |
| P/E | (10.9x) | XXX | (11.9x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (11.3x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified FluoGuide Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
FluoGuide Margins & Growth Rates
FluoGuide's revenue in the last fiscal year grew by —.
FluoGuide's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.8M for the same period.
FluoGuide Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA Growth | 16% | XXX | 30% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.8M | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
FluoGuide Public Comps
See public comps and valuation multiples for other Medical Devices and Medical Imaging & Diagnostics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| FluoGuide | XXX | XXX | XXX | XXX | XXX | XXX |
| Sensus Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Bioporto | XXX | XXX | XXX | XXX | XXX | XXX |
| Exagen | XXX | XXX | XXX | XXX | XXX | XXX |
| Aiforia | XXX | XXX | XXX | XXX | XXX | XXX |
| Applied BioCode | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
FluoGuide M&A Activity
FluoGuide acquired XXX companies to date.
Last acquisition by FluoGuide was on XXXXXXXX, XXXXX. FluoGuide acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by FluoGuide
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialFluoGuide Investment Activity
FluoGuide invested in XXX companies to date.
FluoGuide made its latest investment on XXXXXXXX, XXXXX. FluoGuide invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by FluoGuide
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout FluoGuide
| When was FluoGuide founded? | FluoGuide was founded in 2018. |
| Where is FluoGuide headquartered? | FluoGuide is headquartered in Denmark. |
| How many employees does FluoGuide have? | As of today, FluoGuide has over 8 employees. |
| Is FluoGuide publicly listed? | Yes, FluoGuide is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of FluoGuide? | FluoGuide trades under FLUO ticker. |
| When did FluoGuide go public? | FluoGuide went public in 2019. |
| Who are competitors of FluoGuide? | FluoGuide main competitors are Sensus Healthcare, Bioporto, Exagen, Aiforia. |
| What is the current market cap of FluoGuide? | FluoGuide's current market cap is $74M. |
| Is FluoGuide profitable? | No, FluoGuide is not profitable. |
| What is the current EBITDA of FluoGuide? | FluoGuide has negative EBITDA and is not profitable. |
| What is the current EV/EBITDA multiple of FluoGuide? | Current EBITDA multiple of FluoGuide is (9.8x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.